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Molecular Mechanisms behind 
Initiation of Focal Seizure 
in Temporal Lobe Epilepsy: 
Computational Study
Ruchi Jakhmola Mani and Deepshikha Pande Katare
Abstract
Epilepsy is a noncommunicable disease of the brain that affects people of all 
ages. The chapter aims to identify protein targets and their mechanism of action 
behind temporal lobe epilepsy. Differentially expressed proteins in temporal 
lobe epilepsy (TLE) were used to derive a hypothesis demonstrating routes of 
protein interactions causing focal seizure and identification of putative target 
receptor for its treatment. Text mining was done by constructing a Boolean query 
with keywords such as temporal lobe epilepsy, focal seizures, proteomics, etc., 
in different scientific search engines. The proteins were further used for creating 
protein interaction network and analysed for their role in focal epileptic seizure 
pathway. The most appropriate route for initiation of seizure was observed to 
be route 3. It describes the dysregulated signal transduction from adenosine A1 
receptor (ADORA1) to gamma-aminobutyric acid (GABA) B receptor 1 (GABBR1). 
This causes electrical imbalance and hyper-excitation of neurons that lead to focal 
seizure. The study also predicts that YWHAZ (3-monooxygenase/tryptophan 
5-monooxygenase activation protein zeta) could be the potential target for pre-
venting focal seizures. The network framed in this study is ideal for studying the 
cascades of events that may occur during focal seizures in TLE and is useful in drug 
discovery.
Keywords: temporal lobe epilepsy, focal seizures
1. What is epilepsy?
Epilepsy is the world’s fourth most common neurological disorders. As indicated 
by the International League Against Epilepsy (ILAE), seizure is a transient of signs 
or appearances on the account of irregular, over the top, or synchronous neuronal 
development in the cerebrum. According to the WHO, 50 million people worldwide 
have epilepsy, and it is the fourth most common disease after Alzheimer’s [1]. 
Epilepsy is an electrical unevenness in the cerebrum because of a few reasons like 
inactive way of life, hereditary distortions, hypoxic conditions, cranial harm, aggra-
vation, or expansion in oxidative anxiety levels in the body, et cetera. A seizure is a 
sudden surge of electrical movement in the cerebrum. Seizures control how a man 
shows up or represents a brief span period. Neuronal cells either energize or repress 
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(stop) other neuronal cells from sending messages. As a rule, there is an equaliza-
tion of cells that energize and stop these messages. However, when a seizure occurs, 
there might be a lot of or too little action, bringing about an imbalance in the middle 
of exciting and halting movement. The nature of seizures varies, because the lobes 
of the brain control different behaviors, movements, and experiences. The accurate 
reason for a seizure is still obscure.
Some common causes of epilepsy are as follows:
• Low oxygen during birth
• Head injuries that occur during birth or due to accidents during youth or 
adulthood
• Brain tumors
• Genetic conditions that result in brain injury, such as tuberous sclerosis
• Infections such as meningitis or encephalitis
Because epilepsy is caused by abnormal activity in brain cells, seizures can affect 
any process your brain coordinates. Seizure signs and symptoms may include:
• Temporary confusion
• A staring spell
• Uncontrollable jerking movements of the arms and legs
• Loss of consciousness or awareness
• Psychic symptoms
Symptoms vary depending on the type of seizure. In most cases, a person with 
epilepsy will tend to have the same type of seizure each time, so the symptoms will 
be similar from episode to episode.
2. Focal seizures
Epilepsy comprises of more than 40 clinical disorders and is characterized by 
repeated seizures. Approximately 30% of patients treated with antiepileptic drugs 
(AEDs) are lacking control on seizures [2]. Seizure is a transient state of electrical 
imbalance in the brain. There are different types of seizures such as generalized, 
focal, and other types which hinder the normal functioning of the brain and cause 
epilepsy. Temporal lobe epilepsy is the most common seizure disorder in adults. The 
main cause for TLE is hippocampal sclerosis, and it constitutes around 80% of TLE 
cases [3]. The incidence rate of TLE was reported as 10.4 per 100, and its prevalence 
is 1.7 per 1000 people [4, 5]. TLE can be sporadic, ordinarily with a positive family 
history, or it can give clear familial repeat [6]. There is 70% of neuronal loss within 
the hippocampal region along with repeated focal seizures [7]. The regular clini-
cal signs of focal seizures include gazing, absence of responsiveness, and mouth 
or hand automatisms. Focal seizure is mainly caused by the malfunction of ion 
channels. External stimuli like infection, tumors, and cranial injuries upregulate 
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adenosine and increase the permeability of the blood-brain barrier which results in 
excessive influx of neurotransmitters into the hippocampal region. Lesser reuptake 
of these inhibitory neurotransmitters like gamma-aminobutyric acid (GABA) and 
glutamate by the receptors from the synaptic cleft causes neuroexcitation [8].
A recent study showed that GABA levels were found to be lower in diseased 
state than normal conditions. GABA system and receptor agonists have been used 
in the past for decreasing the effect of a seizure [9]. AEDs such as benzodiazepines 
(including clonazepam and clobazam) increase the frequency of opening of GABA 
receptors, and barbiturates (such as phenobarbitone) increase the time period for 
receptor opening. Thus, these drugs affect the release and movement of GABA [10]. 
Besides their positive effects on cognition ability and behavioral domain, AEDs 
have adverse effects on human health.
In this chapter we have hypothesized a protein-protein interaction network 
which proposes a possible mechanism underlying a focal seizure at a molecular 
level. Several proteins in this pathway were differentially regulated which initiates a 
cascade of events downstream that negatively regulates GABA [11]. The downregu-
lation of GABA causes electrical imbalance in the brain and hence leads to focal 
seizure. Although drugs are available for treating TLE, prevention from its side 
effects is questionable; therefore, we have proposed new receptor for preventing 
seizures.
3. Building a hypothesis
3.1 Building a local protein database for network assessment
Text mining was done by constructing a Boolean query with keywords such as 
temporal lobe epilepsy, focal seizures, proteomics, differential expression, and 
human in different scientific search engines and databases like PubMed Central, 
ScienceDirect, and Google Scholar. Several combinations of keywords were used to 
fetch research articles according to the study. Many research articles were obtained 
and screened manually for differentially expressed proteins in TLE. The proteins 
were further used to create protein-interaction network.
3.2 Creation of protein interaction network
Protein accession numbers were submitted to Cytoscape v2.6 software as query, 
and it gave a master network between the query proteins. The master network com-
prised of query proteins and their interacting partners. This network was created 
by BioGRID, IntAct, and other protein-protein interaction databases included in 
the Cytoscape framework. This network was accompanied with the most followed 
pathways ranked according to their e-values. E-value is an indicator that the results 
are independent of the protein queries chosen and the master network is unbiased 
i.e. the network is based on experimentally verified protein-protein interactions and 
hence are reflected in the network.
3.3 Framing and analysis of hypothesis
The master network was studied, and the proteins exclusively responsible for 
a focal seizure were extracted and linked to formulate a pathway that might be 
responsible for causing seizure in an epileptic brain. This hypothesis was formu-
lated in a stepwise manner, and it explains the series of interactions that might 
occur in the brain during the initiation of a focal seizure in TLE.
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4. Results
Proteins involved in TLE were collected after extensive literature survey. The 
network is in the form of ball and sticks. Balls represent protein nodes, and sticks 
represent the interaction between them. The proteins immediately next to the query 
proteins are called as first neighbors. These first neighbors are later connected to 
second neighbors and so on (Figure 1). The extensive networking between these 
proteins indicates their involvement in similar pathways or processes.
A total of 668 neighbor proteins were retrieved for query proteins. They were 
colored in white and gray balls. White balls represent the proteins following the 
similar pathways as do the query proteins, whereas the gray balls represent the 
proteins following dissimilar different pathways. The query and neighbor pro-
teins were observed to be following NGF, NT, adhesion, MAPK, and few more 
pathways.
We have hypothesized a network of proteins which is suggested to be the mecha-
nism behind seizures (Figure 2). The interactions were later segregated into smaller 
routes to understand the flow of information inside the brain during a seizure 
(Figure 3(a)–(d)). The starting point for the current study of routes was finalized 
to be adenosine A1 receptor (ADORA1), while the last (effector molecule) was 
chosen to be gamma-aminobutyric acid B receptor 1 (GABBR1), we have limited 
our hypothesis between these two proteins.
4.1 Route 1
Adenosine is observed to be upregulated in TLE. Later it binds with ADORA1 
and inhibits the signal transducer activity of GNAS (guanine nucleotide-binding 
protein G(s) subunit alpha isoforms XLas) protein [12]. Further, GNAS which 
stimulates the activity of adenylate cyclase type 5 (ADCY5) when inhibited leads to 
inhibition of ADCY5, and as a result there is no production of secondary messenger 
cAMP (Figure 3(a)) [13]. ADCY5 is also regulated by protein kinase C alpha type 
(PRKCA), and it inhibits its catalytic activity. YWHAZ then acts as an adaptor 
Figure 1. 
The network generated by Cytoscapev2.7.2. The figure represents the master network, i.e., clusters of proteins 
communicating with each other during TLE conditions. It also reports the pathways mostly followed by the 
proteins involved in this network.
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protein which interacts with PRKCA signaling molecule [14]. Ultimately YWHAZ 
negatively regulates GABA causing neuroexcitation, and hence seizure occurs [15].
Alternatively, ADORA1 is also inversely proportional to regulators of G protein 
signaling 3 (RGS3) which are G protein signaling molecules. RGS3 is downregu-
lated by YWHAZ, causing no activation of MAP kinases which leads to altered cell 
growth and proliferation [16].
4.2 Route 2
Upregulation of adenosine in the body results in increased permeability of the 
BBB which leads to excessive influx of neurotransmitters [7]. Due to lesser reuptake 
Figure 2. 
Pictorial representation of seizure events in the brain during generalized seizures. The figure shows the detailed 
graphic representation of events occurring in the brain during focal seizure. Proteins involved in the hypothesis 
are shown in blue color. The process is redrawn as a simplified diagram for easy understanding.
Figure 3. 
The possible routes involved in a seizure: (a) route 1, (b) route 2, (c) route 3, and (d) simplified diagram of 
cumulative routes. The figure represents the different hypotheses of focal seizure generation via three different routes.
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of these neurotransmitters by DRD1(dopamine receptor D1), it inhibits the activity 
of ADCY5 leading to decreased production of cAMP(secondary messenger) [17]. 
Coupling of DRD1 and glutamate receptor, ionotropic, N-methyl, D-aspartate 1 
(GRIN1) causes inhibition of NMDA glutamate receptor-gated currents. GRIN 
1 and glutamate receptor, ionotropic, N-methyl, D-aspartate 2A (GRIN 2A) are 
subunits of NMDA receptor [18]. Missense mutation in GRIN2A initiates phospho-
lipase c, gamma 1 (PLCG1)19. Initiation of PLCG1 separates phosphatidylinositol 
4, 5-bisphosphate (PIP2) into the second messengers, diacylglycerol (DAG) and 
inositol 1, 4, 5-trisphosphate (IP3), which play a vital role in intracellular signal 
transduction. An interruption in this signaling pathway causes altered synaptic 
transmission (Figure 3(b)) [19]. When mutated GRIN2A interacts with PLCG1, it 
causes hindrance in the production of secondary messengers and ultimately alters 
the intracellular signal transduction. Thereafter, PLCG1 does not activate, and no 
phosphorylation of tyrosine kinases takes place. It further causes no stimulation 
of insulin receptor substrate 2 (IRS2) [20]. This results in negative regulation of 
insulin which is facilitated by association of IRS2 and YWHAZ. Then, YWHAZ 
ultimately downregulates GABA, causing a seizure.
Alternatively, it is known that GRIN1 is also responsible for verbal memory and 
its inhibition causes speech impairment during a seizure (Figure 3(b)). GRIN2A 
is significant for neuronal activity and development. But a missense mutation of 
GRIN2A leads to abnormal neuronal ion flux and electrical transmission leading 
to developmental abnormalities [21]. GRIN1 and GRIN2A are the two subunits of 
NMDA glutamate receptor. Mutated GRIN2A causes excessive Ca2+ influx which 
causes conversion of P35 to P25 by calcium-dependent protease, calpain, during 
neurotoxicity and contributes to the pathological state. Elevation in levels of P25 
leads to hyperactivation of cyclin-dependent kinase 5 (CDK5) which causes impair-
ment in behavior, cognition, and synaptic plasticity [22]. Further elevated levels 
of CDK5 and oxidative stress phosphorylates ABL proto-oncogene 1, non-receptor 
tyrosine kinase (ABL-1) which is a ubiquitous non-receptor tyrosine kinase which 
promotes apoptosis and cytoskeleton remodeling [23]. ABL-1 in response to 
oxidative stress downregulates catalase (CAT) activity [24]. CAT binds actively 
to tyrosine-protein phosphatase non-receptor 11 (PTPN11) which is responsible 
for RAS/MAPK signaling which further leads to apoptosis. Low levels of CAT 
cause decreased resistance of PTPN11 toward hydrogen peroxide [25]. PTPN11 is 
phosphorylated by PRKCA, triggering neuronal death. YWHAZ acts as an adaptor 
protein which interacts with PRKCA signaling molecule. In response to DNA dam-
age, ABL-1 is targeted into the nucleus, and it phosphorylates YWHAZ causing the 
activation of JNK signaling which is responsible for apoptosis [26].
4.3 Route 3
ADORA1 is activated by the upregulation of adenosine due to any external 
stimulus [27]. As a result, the permeability of BBB increases causing influx of 
calcium ions. Further, activation of ADORA1 causes downregulation of spectrin 
alpha chain, non-erythrocytic 1 (SPTAN1) which regulates the entry of calcium 
ions in neurons [27]. Due to decreased availability of calcium ions, DMD (dys-
trophin) is upregulated, and no proper synaptic transmission takes place [28]. 
Simultaneously, SPTAN1 interacts with glutathione S-transferase P (GSTP1) which 
is an antioxidant enzyme, regulating CDK5; downregulation of GSTP1 causes 
downregulation of CDK5; hence neurodegeneration initiates. On the other hand, 
DMD interacts with brain-derived neurotrophic factor (BDNF) which controls the 
neuronal excitability, is upregulated, and causes hyperexcitability [29]. BDNF and 
GSTP1 together interact with HSPD1 (60 kDa heat shock protein, mitochondrial), 
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which prevents misfolding of proteins, but it gets upregulated [30]. HSPD1 binds 
to five more proteins, namely, myelin basic protein (MBP), serum albumin (ALB), 
heat shock-related 70 kDa protein 2 (HSPA2), protein deglycase DJ-1 (PARK7), 
and cellular tumor antigen p53 (TP53). MBP forms the myelin sheath of a neu-
ron, and its upregulation causes dysfunctioning of protein. The upregulation of 
ALB hinders its binding to the calcium ions which are leaked from the BBB and 
alter the osmotic pressure of neuronal cells [31]. Further HSPA2, which prevents 
aggregation of proteins, gets upregulated, it does not perform its function properly. 
PARK7 in response to increased oxidative stress does not perform its function of 
reducing the number of free radicals. The upregulation of TP53, a tumor suppres-
sor protein, results in downregulation of apoptosis regulator Bcl-2 (BCL-2). BCL-2 
induces apoptosis and causes neurodegeneration [32]. Further, TP53 interacts with 
YWHAZ which in response to oxidative stress arrests the cell cycle [33]. TP53 also 
interacts with dihydropyrimidinase-related protein 2 (DPYSL2) and death-associ-
ated protein kinase 1 (DAPK1). DPYSL2 modulates the growth of neurons which is 
upregulated and causes hindrance in transmission of electric signals, causing focal 
seizures. Normally, DAPK1 prevents autophagy in normal conditions, when the cell 
is under stress, it is elevated and causes destruction of neuronal cells [34].
From the abovementioned theories, the nearest and most realistic route for caus-
ing seizure generation is proposed to be route 3. This pathway was picked because it 
has those proteins which are differentially regulated and cause electrical irregular-
ity in the brain, bringing on a focal seizure. Repetitive seizures cause weaknesses 
in cognizance, learning, and memory. Also, it has been seen the GABA levels were 
found to be low in brain tissue of epileptic patients. Real occasions during focal 
seizure are transformation of GRIN2A which brings about hindrance in neuronal 
particle flux. Our study concludes that the extended protein signal finally reaches 
to YWHAZ which causes hyperexcitation. This was due to inefficient binding of 
GABA to GABBR1 receptor (Figure 2).
5. Conclusion
The study hypothesized the series of protein-protein interactions which may 
potentially occur during a focal seizure. Out of the three plausible paths for the 
initiation of focal seizure, the most appropriate is route 3 which starts with upregu-
lation of adenosine. Route 3 causes cell cycle arrest and starts the apoptosis of 
neuronal cells along with the hindrance in synaptic transmission [35].
Although AEDs have been formulated for numerous receptors, its generation 
is still an unresolved question. A study by Steinlein et al. showed that mutations in 
genes encoding for voltage-gated and ligand-gated ion channels like GABBR1 recep-
tors and nicotinic acetylcholine receptors are mutated. These mutated receptors 
cause electrical imbalance in the brain [36].
Similarly, a study by Suls et al. suggested that some proteins undergo genetic 
mutations in TLE [37]. In the past research, it has been seen that mutations in 
GLUT1 causes epilepsy. GLUT1 is the major receptor for gluten molecule. GLUT1 
mutation imbalances the concentration of gluten, K+, and albumin across the BBB 
and impairs the K+ buffering in the brain. Gluten metabolism and transport is also 
disturbed which becomes the major reason for neuronal excitability [38]. Some 
studies also suggested that seizure is caused due to mutation in CDK5 [39]. The 
modulation of GABAergic inhibition by NMDA receptors may cause the synaptic 
plasticity [40].
On the other hand, excessive influx of calcium ions leads to hindered synaptic 
transmission [35], due to which heat shock proteins are unable to perform their 
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normal function. In response to oxidative stress proteins like BDNF, MBP, ALB, 
and TP53, DPYSL2 gets upregulated and induces apoptosis, hence causing neuro-
degeneration [22]. Then, YWHAZ finally binds to GABBR1 (helps in preventing 
ion leakage on the membrane and neuronal hyperactivity) and makes it unable to 
bind to GABA, which is an inhibitory neurotransmitter. Therefore, YWHAZ can be 
studied in future as a drug target for epileptic focal seizures.
To date, there were just a couple of protein receptors targeted for antiepileptic 
drugs which manage the pathology. Also, there are no medications to prevent a sei-
zure, and no such receptor has been predicted for the same. Therefore, the present 
study proposes that the proteins involved in route 3 may give some understanding 
into the fundamental mechanism behind seizures. Protein that can be focused for 
designing AEDs can be YWHAZ.
Acknowledgements
We would like to acknowledge Dr. Ashok K. Chauhan, Founder President, Amity 
University Uttar Pradesh, Noida, for providing the infrastructure and support.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
9Molecular Mechanisms behind Initiation of Focal Seizure in Temporal Lobe Epilepsy…
DOI: http://dx.doi.org/10.5772/intechopen.92846
References
[1] Banerjee PN, Filippi D, 
Hauser WA. The descriptive 
epidemiology of epilepsy—A review. 
Epilepsy Research. 2009;85:31-45
[2] Schiffer RB, Babigian HM. Behavioral 
disorders in multiple sclerosis, temporal 
lobe epilepsy, and amyotrophic 
lateral sclerosis: An epidemiologic 
study. Archives of Neurology. 
1984;41:1067-1069
[3] Haneef Z, Lenartowicz A, Yeh HJ,  
et al. Functional connectivity of 
hippocampal networks in temporal lobe 
epilepsy. Epilepsia. 2014;55:137-145
[4] Clancy MJ, Clarke MC, Connor DJ, 
et al. The prevalence of psychosis in 
epilepsy; a systematic review and meta-
analysis. BMC Psychiatry. 2014;14:1
[5] Rigau V, Morin M, Rousset MC, et al. 
Angiogenesis is associated with blood–
brain barrier permeability in temporal 
lobe epilepsy. Brain. 2007;130:1942-1956
[6] Bedner P et al. Astrocyte uncoupling 
as a cause of human temporal lobe 
epilepsy. Brain. 2015;138(5):1208-1222
[7] Lapointe E, Deacon C, Bocti C, 
et al. Temporal lobe atrophy: Frequent 
in elderly with epilepsy of unknown 
etiology. Clinical Neurophysiology. 
2016;127:e161
[8] Ben-Ari Y, Khalilov I, Kahle KT, et al. 
The GABA excitatory/inhibitory shift 
in brain maturation and neurological 
disorders. The Neuroscientist. 
2012;18:467-486
[9] Briggs SW, Galanopoulou AS. Altered 
GABA signaling in early life epilepsies. 
Neural Plasticity. 2011;2011. Article ID 
527605
[10] Jacob TC, Moss SJ, Jurd R. GABAA 
receptor trafficking and its role 
in the dynamic modulation of 
neuronal inhibition. Nature Reviews. 
Neuroscience. 2008;9:331-343
[11] Sebba J, Hogg LLJ. Profound 
Retardation and Multiple Impairment: 
Volume 3: Medical and Physical  
Care and Management. Springer;  
1 Dec 2013
[12] Baraldi PG, Tabrizi MA, 
Fruttarolo F, et al. Recent improvements 
in the development of A2B adenosine 
receptor agonists. Purinergic Signal. 
2008;4:287-303
[13] Hampton M, Melvin RG, 
Andrews MT. Transcriptomic  
analysis of brown adipose tissue  
across the physiological extremes 
of natural hibernation. PLOS One. 
2013;8:e85157
[14] Gannon-Murakami L, 
Murakami K. Selective association 
of protein kinase C with 14-3-3 ζ 
in neuronally differentiated PC12 
cells stimulatory and inhibitory 
effect of 14-3-3 ζ in vivo. The 
Journal of Biological Chemistry. 
2002;277:23116-23122
[15] Couve A, Kittler JT, Uren JM, 
et al. Association of GABA B receptors 
and members of the 14-3-3 family 
of signaling proteins. Molecular 
and Cellular Neurosciences. 
2001;17:317-328
[16] Kleppe R, Rosati S, Jorge- 
Finnigan A, et al. Phosphorylation 
dependence and stoichiometry of 
the complex formed by tyrosine 
hydroxylase and 14-3-3γ.  
Molecular & Cellular Proteomics. 
2014;13:2017-2030
[17] Levy F, de Leon J. Dopamine 
ADHD/OCD theories: Is glutamine part 
of the story? Neurotransmitter. 2015;2
[18] Petralia RS, Al-Hallaq RA, 
Wenthold RJ. Trafficking and targeting 
Neurodegenerative Diseases - Molecular Mechanisms and Current Therapeutic Approaches
10
of NMDA receptors. Biology of the 
NMDA Receptor. 2009;1:149-200
[19] Jang HJ, Yang YR, Kim JK, et al. 
Phospholipase C-γ1 involved in brain 
disorders. Advances in Biological 
Regulation. 2013;53:51-62
[20] Ghorbani S, Fossbakk A, Jorge- 
Finnigan A, et al. Regulation of 
tyrosine hydroxylase is preserved across 
different homo-and heterodimeric 
14-3-3 proteins. Amino Acids. 
2016;48:1221-1229
[21] Clasadonte J, Dong J, Hines DJ, et al. 
Astrocyte control of synaptic NMDA 
receptors contributes to the progressive 
development of temporal lobe epilepsy. 
Proceedings of the National Academy of 
Sciences. 2013;110:17540-17545
[22] Hawasli AH, Bibb JA. Alternative 
roles for Cdk5 in learning and synaptic 
plasticity. Biotechnology Journal. 
2007;2:941-948
[23] Chen L, Wang Z, Tang B, et al. 
Altered expression of c-Abl in patients 
with epilepsy and in a rat model. 
Synapse. 2014;68:306-316
[24] Cao C, Leng Y, Kufe D. Catalase 
activity is regulated by c-Abl and 
Arg in the oxidative stress response. 
The Journal of Biological Chemistry. 
2003;278:29667-29675
[25] Yano S, Arroyo N, Yano N. SHP2 
binds catalase and acquires a hydrogen 
peroxide-resistant phosphatase activity 
via integrin-signaling. FEBS Letters. 
2004;577:327-332
[26] Yoshida K, Yamaguchi T, Natsume T, 
et al. JNK phosphorylation of 14-3-3 
proteins regulates nuclear targeting 
of c-Abl in the apoptotic response to 
DNA damage. Nature Cell Biology. 
2005;7:278-285
[27] da Silva Fernandes MJ, Amorim RP, 
Carneiro JE, et al. Proteomics-based 
strategy to identify biomarkers and 
pharmacological targets in temporal 
lobe epilepsy. In: Pharmacoresistance 
in Epilepsy. New York: Springer; 2013. 
pp. 115-126
[28] Lee TS, Eid T, Mane S, et al. 
Aquaporin-4 is increased in the sclerotic 
hippocampus in human temporal 
lobe epilepsy. Acta Neuropathologica. 
2004;108:493-502
[29] Sadakata T, Shinoda Y, Oka M, 
et al. Reduced axonal localization of 
a Caps2 splice variant impairs axonal 
release of BDNF and causes autistic-
like behavior in mice. Proceedings of 
the National Academy of Sciences. 
2012;109:21104-21109
[30] Gammazza AM, Colangeli R, 
Orban G, et al. Hsp60 response in 
experimental and human temporal lobe 
epilepsy. Scientific Reports. 2015;5
[31] Van Vliet EA, da Costa AS, 
Redeker S, et al. Blood–brain barrier 
leakage may lead to progression 
of temporal lobe epilepsy. Brain. 
2007;130:521-534
[32] Kilany A, Raouf ER, Gaber AA, 
et al. Elevated serum Bcl-2 in children 
with temporal lobe epilepsy. Seizure. 
2012;21:250-253
[33] Waterman MJ, Stavridi ES, 
Waterman JL, et al. ATM-dependent 
activation of p53 involves 
dephosphorylation and association 
with 14-3-3 proteins. Nature Genetics. 
1998;19:175-178
[34] Hainsworth AH, Allsopp RC, Jim A, 
et al. Death-associated protein kinase 
(DAPK1) in cerebral cortex of late-onset 
Alzheimer's disease patients and aged 
controls. Neuropathology and Applied 
Neurobiology. 2010;36:17-24
[35] Voss LJ, Jacobson G, Sleigh JW. 
Bridging the Gap—Understanding 
the Role of Gap Junctions in Seizures. 
IntechOpen Access Publisher; 2011
11
Molecular Mechanisms behind Initiation of Focal Seizure in Temporal Lobe Epilepsy…
DOI: http://dx.doi.org/10.5772/intechopen.92846
[36] White HS, Smith MD, 
Wilcox KS. Mechanisms of action 
of antiepileptic drugs. International 
Review of Neurobiology. 2007;81:85-110
[37] Scheffer IE, Berkovic SF. The 
genetics of human epilepsy. Trends 
in Pharmacological Sciences. 
2003;24:428-433
[38] Suls A, Mullen SA, Weber YG, et al. 
Early-onset absence epilepsy caused by 
mutations in the glucose transporter 
GLUT1. Annals of Neurology. 
2009;66:415-419
[39] Castrén M, Gaily E, 
Tengström C, et al. Epilepsy caused by 
CDKL5 mutations. European Journal of 
Paediatric Neurology. 2011;15(1):65-69
[40] Stelzer A, Slater NT, 
Bruggencate GT. Activation of NMDA 
receptors blocks GABAergic inhibition 
in an in vitro model of epilepsy. Nature. 
1987;326(6114):698-701
